FDA Approves Advanced Insulin Delivery Systems for Type 1 Diabetes.

The FDA has cleared the Beta Bionics iLet ACE Pump and iLet Dosing Decision Software for people with type 1 diabetes. The iLet Bionic Pancreas uses an algorithm to determine and command insulin delivery, removing the need for manual adjustments. The iLet device also simplifies use at mealtime by replacing conventional carb counting with a new meal announcement feature. The FDA is committed to advancing new device innovation that can improve the health and quality of life for people living with chronic diseases that require day-to-day maintenance like diabetes through precision medicine approaches.